Cancer

SpyBiotech Appoints Keith Dewedoff as new Chief Financial Officer

OXFORD, England and CAMBRIDGE, Mass., June 18, 2024 /PRNewswire/ -- SpyBiotech, a biotechnology company with a novel vaccine platform technology…

7 months ago

Roche receives FDA clearance on its digital pathology solution for diagnostic use

The solution, which includes the VENTANA DP 200 slide scanner, Roche's digital pathology workflow software and a display, is now…

7 months ago

EHEALTH TECHNOLOGIES PARTNERS WITH CANCERX AND WHITE HOUSE CANCER MOONSHOT

PITTSBURGH, June 17, 2024 /PRNewswire/ -- eHealth Technologies -- a leading healthcare technology company that provides a patented cutting-edge technology…

7 months ago

Renowned Public Health Expert Prof. Siegal Sadetzki Joins Briya

TEL AVIV, Israel, June 17, 2024 /PRNewswire/ -- Briya, a leading medical data retrieval network, proudly announces the appointment of…

7 months ago

SafeRide Health CEO and Co-Founder Wins EY Entrepreneur of the Year® 2024 Gulf South Award

Celebrating the bold leaders who disrupt markets, revolutionize industries, and transform lives AUSTIN, Texas, June 17, 2024 /PRNewswire/ -- Ernst…

7 months ago

CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment

Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2…

7 months ago

iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer

WATERTOWN, Mass. and GOSSELIES, Belgium, June 17, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical…

7 months ago

Curium Continues to Make Strong Progress in European Roll-Out Of PYLCLARI® – 18F-PSMA PET Diagnostics of Patients With Prostate Cancer

First doses of PYLCLARI® administered in Austria in early May 2024PYLCLARI® now available in France, Germany, Greece, Italy, and the…

7 months ago